Without routine screenings, colorectal cancer may be detected in later stages, when survival rates are lower and more complex care may be required. Hear from Dr. Lisa Ravindra about some long-term impacts of the pandemic on cancer screening and explore your options to get screened.
We’re proud to announce our ongoing collaboration with Katie Couric Media, just in time for Colorectal Cancer Awareness Month. Our goal is to share stories that empower patients and spark conversations about the changing nature of cancer care. Read the first piece of the month, about what younger people should know about colorectal cancer.
Our portfolio of Oncotype DX® tests are supported by a significant amount of clinical evidence, including 125 clinical studies involving 140,000 patients and more than 150 journal publications. This rigorous science helps physicians optimize treatment decisions for breast, colon, and prostate cancer patients. Learn more about our Precision Oncology portfolio and view open positions in your area to join our fight against cancer.
An estimated 22 million cancer screenings were missed between March and June of 2020 due to the pandemic. That makes this Cancer Prevention Month even more important. We support National Comprehensive Cancer Network® (NCCN®), American Cancer Society, and other leading health and cancer organizations encouraging the prioritization of safe, appropriate cancer screening.
The pandemic has paused many routine doctor visits and cancer screenings, potentially leaving thousands of cancers undetected. Our team is proud to support Prevent Cancer Foundation as they encourage everyone to reschedule missed appointments and get back on the books.
We are always looking to grow our team with exceptionally talented people who want to be part of something meaningful, and we know that the transitioning military community exemplifies this. Through this partnership, we are thrilled to invite veterans to join us on our mission of changing the way we think about detecting and treating cancer. Learn more: https://exas.co/39LzGF8
As colorectal cancer screening has dramatically fallen during COVID-19, Dr. Paul Limburg encourages patients and their doctors to consider each of the many testing options available. Cologuard®, a screening test that patients can use at home, can provide a convenient way to continue screening during the pandemic. For adults 45 At Avg. Risk. Rx Only. Learn more: https://exas.co/2MoB86Z
Our team is proud that our grant will support Stand Up To Cancer as they assemble a SU2C Colorectal Cancer Health Equity Dream Team, focused on screening among minority and traditionally under served populations. Grants will be awarded to some of the best minds from diverse fields of research, concentrating on new approaches to address health equity. Read more about this opportunity to strengthen communities, while making an impact on colorectal cancer screening rates here:
You don’t need to be a scientist to work at Exact Sciences. Come learn about our open roles in Customer Service, Maintenance, Culinary, Order Entry, and more at our Career Showcase on Thursday, 1/28 from 1-2 PM. RSVP here: Presented in partnership with Workforce Development Board of South Central Wisconsin
Exact Sciences’ portfolio of precision oncology diagnostic solutions, including the Oncotype DX® suite of tests, applies advanced genomic science to provide insights to inform treatment decisions. But how is this different from genetic sciences? Understand the difference between these two sciences through the lens of prostate cancer awareness and treatment.
